Aroa Biosurgery Ltd
ASX:ARX

Watchlist Manager
Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd
ASX:ARX
Watchlist
Price: 0.74 AUD 8.82%
Market Cap: 255.2m AUD
Have any thoughts about
Aroa Biosurgery Ltd?
Write Note
ARX
/
Income Statement
/
Operating Income

Aroa Biosurgery Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aroa Biosurgery Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Aroa Biosurgery Ltd
ASX:ARX
Operating Income
-NZ$10.7m
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pacific Edge Ltd
NZX:PEB
Operating Income
-NZ$33.6m
CAGR 3-Years
-29%
CAGR 5-Years
-13%
CAGR 10-Years
-13%
No Stocks Found

Aroa Biosurgery Ltd
Glance View

Market Cap
255.2m AUD
Industry
Biotechnology

Aroa Biosurgery Ltd. engages in the development of products for wound care and soft tissue regeneration. The firm is engaged in commercializing regenerative tissue substitutes for medical conditions where impaired healing leads to serious consequences for patients. The company designs and manufactures medical products which enable surgeons and clinicians to repair serious tissue injuries. The Company’s solutions include Endoform platform, Wound Care Portfolio and Reinforced Bioscaffolds. The Endoform platform is a building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing. Its wound care products comprise extracellular matrix to manage acute and chronic wounds. The Reinforced Bioscaffolds combine the biologics and synthetics to address the surgical ventral hernia repair solutions.

ARX Intrinsic Value
1.18 AUD
Undervaluation 37%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Aroa Biosurgery Ltd's Operating Income?
Operating Income
-10.7m NZD

Based on the financial report for Mar 31, 2024, Aroa Biosurgery Ltd's Operating Income amounts to -10.7m NZD.

What is Aroa Biosurgery Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
-2%

Over the last year, the Operating Income growth was -243%. The average annual Operating Income growth rates for Aroa Biosurgery Ltd have been -2% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.